Transgenic Mouse Facility

Director: Dietmar J. Kappes, PhD
Contact:  Xiang Hua, MS, Manager
[email protected]
Reimann R442
Location & Phone Reimann R442
Pricing & Scheduling Contact Xiang Hua for pricing and scheduling.


The Transgenic Mouse Facility provides Cancer Center members the ability to introduce, delete or modify endogenous genes to answer questions about gene function. Transgenic and knockout models provide insights into gene regulation, immune system cellular interactions, and the effect of oncogenes on growth and differentiation. Specialized zinc finger nuclease mediated and CRISPR-mediated gene targeting accelerate the generation of knockout and knock-in mice, and allow complex mouse models that were not previously feasible.

This facility supports Fox Chase Cancer Center's Cancer Center Support Grant (CCSG) from the National Cancer Institute.